"ASXL1"-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms

被引：0
|
作者：
Gleitz, Helene F. E. [1 ,2 ]
Schneider, Rebekka K. [1 ,2 ,3 ]
机构：
[1] Erasmus MC, Dept Dev Biol, Rotterdam, Netherlands
[2] Oncode Inst, Erasmus Med Ctr, Rotterdam, Netherlands
[3] Rhein Westfalische TH RWTH Aachen Univ, Inst Biomed Engn, Fac Med, Dept Cell Biol, Aachen, Germany
来源：
HAEMATOLOGICA | 2023年 / 108卷 / 05期
关键词：
STROMAL CELLS;
D O I：
10.3324/haematol.2022.281634
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1203 / 1204
页数：2
相关论文
共 50 条
  • [31] THE ASXL1 GENE ALTERATIONS IN BONE MARROW CELLS OF PATIENTS WITH DELETION 20Q AND MYELOID DISORDERS
    Brezinova, J.
    Sarova, I.
    Lhotska, H.
    Ransdorfova, S.
    Izakova, S.
    Svobodova, K.
    Podskalska, L.
    Markova, J.
    Zemanova, Z.
    Cermak, J.
    Jonasova, A.
    Michalova, K.
    HAEMATOLOGICA, 2016, 101 : 767 - 768
  • [32] TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms
    Soyer, Nur
    Kaymaz, Burcin Tezcanli
    Ozkan, Melda Comert
    Aktan, Cagdas
    Kucukaslan, Ali Sahin
    Sahin, Fahri
    Kosova, Buket
    Saydam, Guray
    TURKISH JOURNAL OF HEMATOLOGY, 2017, 34 (02) : 174 - 178
  • [33] Bone marrow findings post allogeneic transplant for myeloproliferative neoplasms and chronic myelomonocytic leukemia with increased fibrosis
    Gupta, Srishti
    Courville, Elizabeth L.
    LABORATORY MEDICINE, 2024, 55 (05) : 602 - 608
  • [34] Arginase-1+bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver
    Bonometti, Arturo
    Borsani, Oscar
    Rumi, Elisa
    Ferretti, Virginia Valeria
    Dioli, Claudia
    Lucato, Elena
    Paulli, Marco
    Boveri, Emanuela
    CANCER MEDICINE, 2023, 12 (07): : 7815 - 7822
  • [35] TARGETING THE FIBROTIC BONE MARROW NICHE FOR TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
    Campbell, Timothy
    Zhang, Si Yi
    Valencia, Alexander
    Passegue, Emmanuelle
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : S109 - S109
  • [36] ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival
    Argote, Juliana Alvarez
    Dasanu, Constantin A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (05) : 757 - 763
  • [37] Somatic Mutations and Inborn Variants in Exon 12 of ASXL1 in Different Myeloid Neoplasms
    Schnittger, Susanne
    Eder, Christiane
    Fasan, Annette
    Illig, Thomas
    Klopp, Norman
    Wichmann, H. -Erich
    Kern, Wolfgang
    Haferlach, Claudia
    Haferlach, Torsten
    BLOOD, 2011, 118 (21) : 609 - 609
  • [38] Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis
    Benedetta Rambaldi
    Elisa Diral
    Samantha Donsante
    Noemi Di Marzo
    Federica Mottadelli
    Lucia Cardinale
    Erica Dander
    Giuseppe Isimbaldi
    Pietro Pioltelli
    Andrea Biondi
    Mara Riminucci
    Giovanna D’Amico
    Elena Maria Elli
    Alice Pievani
    Marta Serafini
    Annals of Hematology, 2021, 100 : 105 - 116
  • [39] Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis
    Rambaldi, Benedetta
    Diral, Elisa
    Donsante, Samantha
    Di Marzo, Noemi
    Mottadelli, Federica
    Cardinale, Lucia
    Dander, Erica
    Isimbaldi, Giuseppe
    Pioltelli, Pietro
    Biondi, Andrea
    Riminucci, Mara
    D'Amico, Giovanna
    Elli, Elena Maria
    Pievani, Alice
    Serafini, Marta
    ANNALS OF HEMATOLOGY, 2021, 100 (01) : 105 - 116
  • [40] Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
    Brune, Magdalena M.
    Rau, Achim
    Overkamp, Mathis
    Flaadt, Tim
    Bonzheim, Irina
    Schuerch, Christian M.
    Federmann, Birgit
    Dirnhofer, Stefan
    Fend, Falko
    Tzankov, Alexandar
    CANCERS, 2021, 13 (22)
12345